FLAT Study: First Line Ablation Therapy for Treatment of Paroxysmal Atrial Fibrillation (RAAFT)
NCT00137540
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Atrial Fibrillation
Interventions
DEVICE:
RF ablation
DRUG:
anti-arrhythmic drug therapy
Sponsor
Biosense Webster EMEA